Global Tracheobronchial Stents Market, By Type (Self-Expandable Stents, Non-Expandable Stents, Balloon-Expandable Stents), Material (Metal Stents, Silicone Stents, Hybrid Stents), Application (Hospitals, Ambulatory Surgery Centers) – Industry Trends and Forecast to 2029
Market Analysis and Size
Medical devices have transformed a stent from being bare metallic mesh or a silicone tube to being biodegradable and custom made. Tracheobronchial stents are valuable adjuncts to the palliation of patients who suffer from central airway obstruction (CAO).
- These stents are being utilized as a bridge prior to final therapeutic intervention in various benign airway stenosis, malacia, and post-transplant scenarios to manage airway dehiscence. Data Bridge Market Research analyses that the tracheobronchial stents market is expected to reach the value of USD 165.62 million by 2029, at a CAGR of 7.05 during the forecast period. The “self-expandable stents” segment accounts for the largest product segment owing to its various advantages.
Tracheobronchial stenting is defined as an effective and safe procedure that provides rapid palliation of symptoms, and improves patient functional status. The tracheobronchial stents allow physicians to improve airway obstruction of both malignant and benign obstructions. These stents offer the relief of malignant obstructive lesions.
Tracheobronchial Stents Market Dynamics
Rise in Prevalence of Lung Cancer and Respiratory Diseases
The rise in prevalence of lung cancer and respiratory diseases such as chronic obstructive pulmonary disease and asthma, among others across the globe, is one of the major factors driving the market's growth. According to Disease Prevention and Health Promotion (ODPHP), over 25 million people will be diagnosed with asthma, increasing the demand for tracheobronchial stents.
Increase in the Preference for Minimally Invasive Surgeries
The increase in the inclination towards minimally invasive surgeries among the population globally due to the various advantages it offers, including quick recovery and less pain, accelerate the tracheobronchial stents.
The increase in the funding by the federal government to drive the adoption of these devices further influence the market.
Surge in Number of Persons Having Bronchoscopies
The surge in number of bronchoscopy procedures increasing the need for tracheobronchial stents further influence the market.
Additionally, surge in healthcare expenditure, high investment in research and development, surge in funding on healthcare infrastructure, and advanced healthcare healthcare regulatory scenarios positively affect the tracheobronchial stents market.
Furthermore, development of biodegradable and drug-eluting lung stents and emergence of 3D printing of lung stents extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Additionally, introduction of unique and revolutionary tracheobronchial stents will further expand the healthcare interoperability solutions market's growth rate in the future.
On the other hand, availability of alternative treatments and complications associated with stents are expected to obstruct market growth. Also, the decline in the Prevalence of Tobacco Smoking are projected to challenge the tracheobronchial stents market in the forecast period of 2022-2029.
This tracheobronchial stents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tracheobronchial stents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Tracheobronchial Stents Market
A minimal impact of COVID-19 pandemic was witnessed over tracheobronchial stents market. Major minimally invasive surgeries were postponed to reduce the risk of patients being exposed to COVID-19 in hospitals.
- A 3D printed airway stent developed by Cleveland Clinic physician Tom Gildea, M.D. was approved by United States Food and Drug Administration (FDA) in January 2020. These stents are highly beneficial in treating breathing problems as keep airways open.
Global Tracheobronchial Stents Market Scope and Market Size
The healthcare interoperability solutions market is segmented on the basis of type, material and application. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Self-Expandable Stents
- Non-Expandable Stents
- Balloon-Expandable Stents
On the basis of type, tracheobronchial stents market is segmented into self-expandable stents, non-expandable stents and balloon-expandable stents.
- Metal Stents
- Silicone Stents
- Hybrid Stents
Based on material, the tracheobronchial stents market is segmented into metal stents, silicone stents and hybrid stents. Metal stents have been further segmented into nitinol stents, stainless steel stents and others. Metal stents dominate the material segment because of their advantages, such as ease of insertion, thinner walls, and a lower risk of dislodgment or migration.
- Ambulatory Surgery Centers
Tracheobronchial stents market has also been segmented on the basis of application into hospitals and ambulatory surgery centers.
Tracheobronchial Stents Market Regional Analysis/Insights
The tracheobronchial stents market is analysed and market size insights and trends are provided by country, type, material and application as referenced above.
The countries covered in the tracheobronchial stents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the tracheobronchial stents market because of the high prevalence of chronic obstructive pulmonary disease and asthma among people within the region. The increase in number of geriatric population suffering from a respiratory disorder also influences the market.
Europe is expected to witness significant growth during the forecast period of 2022 to 2029 due to the presence of numerous medical centers and higher preference for these stents among surgeons in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The tracheobronchial stents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for tracheobronchial stents market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tracheobronchial stents market. The data is available for historic period 2010-2020.
Competitive Landscape and Tracheobronchial Stents Market Share Analysis
The tracheobronchial stents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tracheobronchial stents market.
Some of the major players operating in the tracheobronchial stents market are Boston Scientific Corporation, Merit Medical Systems, BD, TAEWOONG, Micro-Tech (Nanjing) Co., Ltd., Cook, Novatech SA, M.I.TECH., EFER ENDOSCOPY, Fuji Systems Corp., HOOD LABORATORIES, Meditek Systems Pvt. Ltd., Kapitex Healthcare Ltd., among others.